NOW ENROLLING PHASE III sunRIZE TRIAL In the study of congenital hyperinsulinism

Learn More »
sunrize logo

XOMA 358, a Novel Treatment for Hyperinsulinemic Hypoglycemia: Safety and Clinical Pharmacology from the First in Human Trial

Back to Careers

ENDO 2015 Annual Meeting

Stay Connected

Email Alerts Contacts RSS News Feed
MENU